Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,302
datasets available to search
ShareScore release 0.9.0
Dataset results
2,302 results for “B-cells”
A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies
ClinicalTrials.gov study NCT03310619. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Evaluating the Efficacy and Safety of JCAR015 in Adult B-cell Acute Lymphoblastic Leukemia (B-ALL)
ClinicalTrials.gov study NCT02535364. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant
ClinicalTrials.gov study NCT00622388. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL
ClinicalTrials.gov study NCT02910063. IPD Sharing: YES. Countries: 8. Publications: 1.
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00389818. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT01741792. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell
ClinicalTrials.gov study NCT03677141. IPD Sharing: YES. Countries: 6. Publications: 2.
A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hod
ClinicalTrials.gov study NCT01691898. IPD Sharing: Not stated. Countries: 6. Publications: 3.
Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00274924. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
ClinicalTrials.gov study NCT01193842. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00121199. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma
ClinicalTrials.gov study NCT00446095. IPD Sharing: NO. Countries: 1. Publications: 1.
Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy
ClinicalTrials.gov study NCT01200589. IPD Sharing: Not stated. Countries: 16. Publications: 1.
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
ClinicalTrials.gov study NCT00281918. IPD Sharing: Not stated. Countries: 11. Publications: 11.
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
ClinicalTrials.gov study NCT04464200. IPD Sharing: YES. Countries: 1. Publications: 2.
An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma
ClinicalTrials.gov study NCT02413489. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Short-term B-cell Depletion in Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT03853746. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma
ClinicalTrials.gov study NCT01165112. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant
ClinicalTrials.gov study NCT01431209. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy
ClinicalTrials.gov study NCT01626352. IPD Sharing: Not stated. Countries: 1. Publications: 23.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.